MFGP
PTX

Marshall Financial Group (Pennsylvania)’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Marshall Financial Group (Pennsylvania)’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-63,940
Closed -$27K – 53
2018
Q4 		$27K Buy
+63,940
New +$39.8K 0.03% 50

Marshall Financial Group (Pennsylvania)'s PTX Position: Q1 2019 in Review

Marshall Financial Group (Pennsylvania) sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q1 2019, closing a stake of 63,940 shares — an estimated $27K sold.

Marshall Financial Group (Pennsylvania) first reported a position in PTX in Q4 2018 and held it in 1 quarter. The position peaked at $27K in Q4 2018. 1 fund tracked by Wall St. Rank holds PTX as of Q1 2019.

  • Marshall Financial Group (Pennsylvania) reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q1 2019 after selling out during the quarter.
  • Marshall Financial Group (Pennsylvania) sold 63,940 Pernix Therapeutics Holdings, Inc. shares in Q1 2019, an estimated $27K.
  • Marshall Financial Group (Pennsylvania) first reported a position in Pernix Therapeutics Holdings, Inc. in Q4 2018 and held it in 1 quarter.
  • Marshall Financial Group (Pennsylvania)'s Pernix Therapeutics Holdings, Inc. position peaked at $27K in Q4 2018.
  • 1 fund tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q1 2019.

Based on Marshall Financial Group (Pennsylvania)'s 13F filing for Q1 2019, filed 26 Apr 2019.